NVCR
NovoCure Ltd.
NASDAQ · Healthcare · Medical - Instruments & Supplies · JE
$14.59
+8.64%Margins
Gross margin
77.0%
EBITDA margin
-14.4%
EBIT margin
-17.2%
Net margin
-16.8%
FCF margin
-2.8%
-34.7%
Return on equity
-14.7%
Return on assets
-21.4%
Return on invested capital
0.89x
Asset turnover
$3.6M
Cash from operations
$3.96
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026